Concepedia

P. Douglas Boatman

PD

Statistics

Publications

16

Citations

2.2K

H-Index

16

Active since

1990

Affiliations

Arena Pharmaceuticals (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Texas Tech University

University of Washington

P. Douglas Boatman is an author at Arena Pharmaceuticals (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1990–2017

16

Publications

16

First total synthesis of taxol. 1. Functionalization of the B ring

Robert A. Holton, Carmen Somoza, Hyeong Baik Kim et al. · Journal of the American Chemical Society · 1994 · 629 citations

, , +11

First total synthesis of taxol. 2. Completion of the C and D rings

Robert A. Holton, Hyeong Baik Kim, Carmen Somoza et al. · Journal of the American Chemical Society · 1994 · 524 citations

, , +8

Taxol®: science and applications.

M Suffness, Monroe E. Wall, H. R. Hartzell et al. · 1995 · 336 citations

, , +3

Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression

Brett Lauring, Andrew K.P. Taggart, James R. Tata et al. · Science Translational Medicine · 2012 · 127 citations

, , +8

3-(1<i>H</i>-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

Graeme Semple, Philip J. Skinner, Tawfik Gharbaoui et al. · Journal of Medicinal Chemistry · 2008 · 96 citations · Full text

, , +14

1–5 of 16